| NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
View |
| NCT04707365 |
Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort |
View |
| NCT00882765 |
Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery |
View |
| NCT03818165 |
Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases |
View |
| NCT00079365 |
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas |
View |
| NCT01648465 |
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors |
View |
| NCT03394365 |
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy |
View |
| NCT00622674 |
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors |
View |
| NCT05687474 |
Baby Detect : Genomic Newborn Screening |
View |
| NCT02327065 |
Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion |
View |
| NCT03328065 |
Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, |
View |
| NCT00499265 |
Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery |
View |
| NCT00001165 |
Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas |
View |
| NCT03023722 |
Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer |
View |
| NCT05257122 |
A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer |
View |
| NCT02021422 |
A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy |
View |
| NCT05595122 |
EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction |
View |
| NCT01064622 |
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer |
View |
| NCT06081322 |
A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors |
View |
| NCT04937322 |
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry. |
View |
| NCT01830322 |
Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer |
View |
| NCT01413022 |
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma |
View |
| NCT02115022 |
EUS vs. MDCT in Pancreatic Malignancy |
View |
| NCT02308722 |
SBRT Pre-operatively for Pancreatic Cancer |
View |
| NCT01381822 |
Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors |
View |
